Endothelial Cells at the Crossroad of Atherosclerosis and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Unifying Target for Dual Treatment
JACC Basic Transl Sci. 2026 Jul 10;11(8):101624. doi: 10.1016/j.jacbts.2026.101624. Online ahead of print.ABSTRACTAtherosclerosis and metabolic dysfunction-associated steatotic liver disease (MASLD) are 2 highly prevalent conditions that frequently coexist and amplify each other's clinical burden. M

